Related Experiment Videos
Treatment of in situ ductal breast cancer
1Department of Radiation Oncology, Harvard Medical School, Boston, Mass.
Frontiers of Radiation Therapy and Oncology
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)·2011
Systemic therapy for treating locoregional recurrence in women with breast cancer.
The Cochrane database of systematic reviews·2001
Postmastectomy locoregional radiotherapy: is it here to stay?
Seminars in oncology·2001
Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?
International journal of radiation oncology, biology, physics·2000
Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy.
International journal of radiation oncology, biology, physics·2000
Proton therapy in the clinic.
Frontiers of radiation therapy and oncology·2011
Proton therapy: clinical gains through current and future treatment programs.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiotherapy for prostate cancer: current results of a phase II trial.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for gastrointestinal malignancies.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup and therapy.
Frontiers of radiation therapy and oncology·2011
Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction.
Frontiers of radiation therapy and oncology·2011